临床普外科电子杂志 ›› 2023, Vol. 11 ›› Issue (2): 20-.

• • 上一篇    下一篇

原发性肝癌靶向联合其他治疗的研究现状

  

  1. 1. 赣南医学院 研究生院,江西 赣州 341000;2. 赣南医学院第一附属医院 普外科,江西 赣州 341000
  • 出版日期:2023-04-01 发布日期:2023-05-23

Research status of targeted combination with other therapies for primary liver cancer

  1. 1.Graduate School of Gannan Medical College, Jiangxi Ganzhou 341000, China; 2. General Surgery Department of the First Affiliated Hospital of Gannan Medical College, Jiangxi Ganzhou 341000, China
  • Online:2023-04-01 Published:2023-05-23

摘要:

原发性肝癌在早期缺乏明显且典型的临床表现,一旦出现明显症状或体征,疾病多已进入中晚期,确诊时大多已失去手术的机会,部分可手术患者术后复发快,预后较差。因此,如靶向治疗、免疫治疗、射频消融术、血管介入治疗、中医药治疗等非手术治疗手段,对肝癌中晚期治疗效果显著,尤其肝癌靶向治疗是现在的一个热门话题。在此,本文针对目前肝癌的靶向治疗的研究进展以及联合其他治疗方法的研究现状作一综述。

关键词: 原发性肝癌, 靶向治疗, 联合治疗

Abstract:

Primary liver cancer lacks obvious typical clinical manifestations in the early stage, once obvious symptoms or signs appear, the disease has mostly entered the middle and advanced stages, most of them have lost the opportunity for surgery when they are diagnosed, and some operable patients have early recurrence after surgery and have a poor prognosis. Therefore, non-surgical treatments such as targeted therapy, immunotherapy, radiofrequency ablation, vascular interventional therapy, and traditional Chinese medicine therapy have significant effects on the treatment of liver cancer in the middle and advanced stages, especially targeted therapy for liver cancer is a hot topic now. In this paper, this article reviews the current research progress of targeted therapy for liver cancer and the research status of combination with other treatments.

Key words: Primary liver cancer, Targeted therapy, Combination therapy